During the past decade, Gastroenterology & Liver Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gastroenterology & Liver Institute" are "Cirrhosis" (1 trials), "Hepatitis B" (1 trials), "Hepatocellular Cancer" (1 trials), "Hepatocellular Carcinoma" (1 trials) and "Liver Cancer" (1 trials). Many other conditions were trialed in "Gastroenterology & Liver Institute" in a lesser frequency.

Most popular intervention types in "Gastroenterology & Liver Institute" are "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Oncoguard™ Liver Test" (1 trials), "Standard of Care CT/MRI Imaging" (1 trials) and "Study CT/MRI Imaging" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterology & Liver Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Gastroenterology & Liver Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Gastroenterology & Liver Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterology & Liver Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".